Pharmaceutical Manufacturing in Taiwan

Mds Pharma Services

MDS Pharma Services – The world's premier provider of innovative drug discovery and development solutions. We offer a full spectrum of world-class discovery, preclinical and clinical resources and expertise, strategically located around the world, to meet the needs of the global pharmaceutical and biotech industries. Our broad range of services is designed to increase the speed, precision and productivity of your drug discovery and development activities. Through 2009 and 2010, MDS Inc. divested the assets of MDS Pharma Services- The former discovery and preclinical businesses (Pharmacology/DMPK and Drug Safety Assessment) have been acquired by Ricerca Biosciences LLC- The former early stage clinical research operations (the Development & Regulatory Services consultancy and Early Stage Development business) have been acquired by Celerion Inc- The former late stage clinical research operations (Global Clinical Development) have been acquired by INC Research- The former clinical laboratory operations (Global Clinical Development) have been acquired by Clearstone Central Laboratories.

1001 to 5000 staff

Formosa Laboratories, Inc

Formosa Laboratories, Inc. produces APIs and UV-filters in its modern facilities near Taipei. Its GMP compliance has been approved by DOH of Taiwan, US FDA, BGV of Germany, EDQM and PMDA of Japan. Formosa’s major API products include Vitamin D derivatives (Alfacalcidol, Calcitriol, Calcipotriol, Doxercalciferol, and Paricalcitol), Balsalazide, Benzonatate, Capsaicin, Colesevelam, Gadodiamide, Flupentixol, Melitracen, Meprobamate, Montelukast, Mycophenolate Mofetil, Sevelamer (HCl and Carbonate), and Taltirelin. As a major producer in the world, our UV-filter products include avobenzone and Octinoxate. We also provide custom synthesis service from process development to full commercial production for APIs and other specialty chemicals, with full documentation support.

501 to 1000 staff

Panion & Bf Biotech Inc

Panion & Bf Biotech Inc is a company based in Taiwan. Welcome to join PBF private product demostration group at

501 to 1000 staff

Qps Holdings, Llc

QPS is a GLP/GCP-compliant contract research organization (CRO) delivering the highest grade of discovery, preclinical, and clinical drug development services. An award-winning leader focused on bioanalytics and clinical trials, QPS is known for proven quality standards, technical expertise, a flexible approach to research, client satisfaction and turnkey laboratories and facilities. We are passionate about our work, creating value for patients and customers while generating opportunities for employees to thrive. Since 1995, it has rapidly expanded from a tiny bioanalysis shop to a full-service CRO with 1100+ employees in the US, Europe, India and Asia. Today, it offers expanded pharmaceutical contract R&D services with special expertise in Neuropharmacology, DMPK, Toxicology, Bioanalysis, Translational Medicine, and Clinical Development. Through continual enhancements in capacities and resources, QPS stands tall in its commitment to deliver superior quality, skilled performance and trusted service to its valued customers.

1001 to 5000 staff

Astrazeneca Taiwan

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.

501 to 1000 staff

Anya Biopharm Inc

Anya is a young, agile and innovative publicly listed (TWO: pharmaceutical company founded in Taipei, Taiwan. We started with our flagship program #miraje in late 2016 with our oral peptide delivery platform, currently at clinical stage. The founding team comes with average 15 years of mid-senior level experience in General Management, Business Development and Regulatory Affairs functions at leading generic companies as Sandoz, Alvogen, Biocon and Zydus. Our guiding principles are 3Es - Excellence, Engagement and Efficiency. We also offer consulting services on Market Expansion, Portfolio Development and Business Development services to global companies to establish business and partnerships is Taiwan, Kore and China and offering companies from the region to expand in to US, EU and RoW Markets.

1 to 10 staff

Bora Pharmaceuticals

Bora Pharmaceuticals is a premier international contract development and manufacturing organization (CDMO) specializing in complex oral solid dose, liquids, semi-solids, opthalmics, biologics, and sterile injectable products. We provide early phase clinical through to commercial manufacturing with full packaging capabilities to biopharma companies worldwide. Bora owns and operates in ten state-of-the-art CGMP manufacturing facilities across Asia and North America – delivering to more than 100 markets around the world. Our sites have the highest international standards for manufacturing, packaging, R&D and analytical testing. As a future focused CDMO, we know better than most that our own success is shaped by our partners victories. That's why, when you choose Bora - we make success more certain by following Bora’s 5Ps – Promises, Partnerships, Pride, People, and Progress. These 5 principles are Bora’s Pledge to our customers. Follow us to find out more and keep up to date with Bora Pharmaceuticals.

1001 to 5000 staff

Innopharmax, Inc

INNOPHARMAX develops oral new dosage form new drugs for further clinical development and commercialization, utilizing core drug delivery technology platforms OralPAS®, OralPAS Pro®, and MUCR. We are committed to improve the safety and efficacy of currently available drugs, and provide superior and cost effective medical options.

11 to 50 staff

Tsh Biopharm Corporation Ltd

TSH Biopharm starts in the field of chronic diseases and adheres to the principles of integrity and honesty. With a focus on innovation and excellence, our mission is to provide superior healthcare services for all stages of patient care. Our core products are centered around "patient-centric" treatments, including cardiovascular medications, gastrointestinal medications, and central nervous system medications. We cultivate the niche market of chronic diseases while simultaneously pursuing a dual-engine strategy to pioneer precision medicine and offer comprehensive treatment options. For more information, please visit

51 to 200 staff

Allgenesis Biotherapeutics Inc

Allgenesis is a privately-held, clinical stage ophthalmology company based in Taiwan. The company is focused on novel multi-specific fusion proteins for treating diabetic macular edema and wet-age-related macular degeneration; and small molecule eye drops for dry eye and pterygium diseases.

11 to 50 staff

Efficient Pharma Management Corp

Efficient Pharma Management Corp.(EffPha) provides drug development services for pharmaceutical companies. Our services focus on information integration for the submission package preparation, strategic planning, and efficient management of the clinical study to accelerate your drug development to approval. With extensive regulatory experience and multi-cultural familiarity, EffPha serves as your regional hub in Asia, and bridges the gaps between Asian and global pharmaceutical industries to widen your market reach.

11 to 50 staff

Msd Taiwan

201 to 500 staff

Reber Genetics Co., Ltd

Reber Genetics was founded in 2008 with the objective of becoming a successful biotechnology company devoted to innovative R&D and high-quality products. The mission of Reber Genetics is to deliver preventative health care in animals. To achieve that, we concentrate on the development of highly efficacious, safe animal vaccines. Now we are expanding the product pipeline and aim to bring these innovative vaccine products onto the global markets. We are proud to be the frontrunner in applying state of the art technologies to animal vaccines and we are confident in our ability to create the best solutions for our customers.

51 to 200 staff

Scivision Biotech Inc

SciVision Biotech Inc, founded in 2001, is now a public company listed at Taiwan Stock Exchang (Stock symbol : 1786) SciVision Biotech Inc. manufactures Hyaluronic acid products by using own-developed Cross-linked Hyaluronic Acid Platform (CHAP) to make the characteristics of Hyaluronic acid products be precisely controllable, and can be widely used in the production of cross-linked Hyaluronic acid products with different types and physical properties. The technology of Cross-linked Hyaluronic Acid Platform (CHAP) established the leading position of SciVision Biotech Inc. in the field of medical grade Hyaluronic acid products. The population structures of both developed and developing countries are gradually moving towards an aging society. The pursuit of beauty and health, as well as the demand for medical care of degenerative diseases has increased day by day. The main products of our company are Hyaluronic acid dermal fillers (for medical and cosmetic surgical use), Hyaluronic acid anti-adhesion gels (for surgical use) and Hyaluronic acid viscosupplement (for treatment of knee osteoarthritis). The three Hyaluronic acid products are high-evel medical devices that cater to the commercial possibilities for next 10-year growth. Today, our company has gradually increased the technology scale and is being devoted to the health and beauty fields, to create a better vision and reach the human’s aesthetic realm SciVision Biotech acquired a nearly square meter site located in Kaohsiung Cianjhen Technology Industrial Park for the construction of a new manufacturing facility to accommodate the growing production needs. The facility was GMP certified, and was constructed based on FDA standard, fully equipped with advanced automatic equipment. We work with pharmaceutical and specialty companies worldwide to develop long-term competitiveness. SciVision’s vision is to contribute its accumulated technologies and experience for the benefit of all humankind.

51 to 200 staff

Taiwan Bio-Manufacturing Corporation

Taiwan Bio-Manufacturing Corporation (TBMC), conceived by the Ministry of Economic Affairs and jointly established by the Industrial Technology Research Institute (ITRI) and the Development Center for Biotechnology (DCB), officially commenced operations in May 2023. Dedicated to advancing biomanufacturing capabilities, TBMC partners with National Resilience, Inc.(Resilience), a technology-focused biomanufacturing company. Combining the expertise of National Resilience Inc. and Taiwan’s smart manufacturing capabilities, TBMC is dedicated to developing state-of-the-art solutions for the production of complex medicines, including (i)mRNA drug,(ii)viral therapy, and (iv)CHO-C protein pharmaceutical platforms.

51 to 200 staff

Taiwan Biotech Co., Ltd

Founded in 1945, Taiwan Biotech (TBC) is the first local pharmaceutical company in Taiwan. We have devoted over 75 years to developing and supplying superior generic drugs that cover a variety of therapeutic areas. TBC has established international business and development division since 1996 to promote the products globally and nurtured a stable and continuously-growing sales network across Japan, Southeast Asia, Mainland China, and North America. We strive to innovate and will continue expanding our global footprint.

1001 to 5000 staff

Tty Biopharm Company Limited

TTY Biopharm Co, Ltd. was established on July 22nd 1960. TTY is a Taiwan's leading pharmaceutical manufacturing company which specializes in the development of special formulations and new drugs. TTY focuses on research & development and innovation of antitumor and against severe infection's areas. We will continue to develop in healthcare product portfolio to support the physicians and patients with completed approach to disease treatment. In product development, we continuously build win-win business relationships with partners through innovation derived from our successful “specialty sustained release technology platform”, and continuously enhance our production quality and efficiency through designing customized production protocol. In manufacturing, TTY owns internationalized factories with high-standard quality controlling process and excellent production management. Our manufacturing base was established according to international standards, and it is able to produce drugs of high competitive barriers and added values for global marketing. In marketing, TTY uses the foundation of solid research and development and production capabilities to build global strategic alliances. It also uses self-owned sales teams and company of joint venture to expand markets. TTY now is an innovative,"global marketing and drug development oriented" innovative biotech enterprise. By the incessant improvement in product development, manufacturing and marketing, TTY strives to become the world leading pharmaceutical company specialized in developing and marketing specialty formulation products and biologics.

501 to 1000 staff

Anxo Pharmaceutical Taiwan Co. Ltd

Anxo Pharmaceutical Co. was founded in 2003, we are a technology based specialty pharmaceutical company aimed on development and manufacturing of all pharmaceutical products. Nowadays the environment of international pharmaceutical market and medical health insurance policy have been changed very quickly. In order to provide high quality medicine and advanced technology of pharmaceutical manufacture, ANXO has devoted to invest state of the art equipments, and to build up professional R&D teams dedicated to develop many critical technology platforms for high quality pharmaceutical products in the global market.

201 to 500 staff

Formosa Pharmaceuticals, Inc

Formosa Pharmaceuticals () is a clinical stage biopharmaceutical company with primary focus in ophthalmology and oncology. Our flagship asset, APP13007 (Clobetasol Propionate ophthalmic suspension 0.05%) was recently approved by the US FDA (March, 2024) for the treatment of post-operative inflammation and pain following ocular surgery. In August, 2017, Formosa Pharmaceuticals completed the acquisition of Activus Pharma, based in Funabashi, Japan. With the acquisition of the Activus Pure Nanoparticle Technology (APNT) Platform, Formosa Pharmaceuticals enters the ophthalmology disease area with two late-preclinical assets and the goal of expanding the platform’s scope and application. APNT effectively reduces API particle size to improve dissolution and bioavailability without the drawbacks of heavy metal contamination other platforms often experience.

11 to 50 staff

Dfc - Dah Feng Capsule

Dah Feng Capsule (DFC) is the leading supplier of empty hard capsules in Taiwan. DFC provides safe and reliable empty hard capsules for pharmaceutical and nutraceutical industry, including acid-resistant vegetable capsules, general vegetable capsules and gelatin capsules.We are certified by PIC/S GMP, ISO 9001, and FSSC Established in 1967, DFC has continued to dedicate great efforts in achieving the highest customer satisfaction with over 50 years of experience in the industry. DFC has been the leading supplier of empty hard capsules to major pharmaceutical companies in Taiwan and prestigious nutraceutical producers in the US.

201 to 500 staff

Apple Biomedical

Apple BioMedical Inc. is an ISO13485 certified medical supplier with core competencies in the anatomical / pathological models and medical training devices. Building on 25 years of excellence, we aim to deliver precise and live-saving medical information to the public and to provide vivid visual representation for the world!

11 to 50 staff

Astracrux Clinical Trial And Consulting Inc

AstraCrux Clinical Trial and Consulting assists hospitals, pharmaceutical companies and CRO clients in finding prompt solutions to the legal obstacles involved in running clinical trials and conducting research. We can also offer quality medical science consulting, including product development strategies and clinical trial planning and design, as well as specialist training. Greater China and the Asia-Pacific are our main markets. However, we are also able to provide certain services in some parts of Europe, as well as the US. Our services for Clinical and drafting Clinical Site Agreements (CSAs)/ Clinical Trial Agreements (CTAs)-Review agreements required for clinical trials e.g. CDA, CSA/CTA, Key Opinion Leader Agreements, Service & Consulting Purchase Agreements, Licensing Agreement, Copyright Transfer Agreements & Material Transfer Agreements -Template preparation -Budget negotiations -Complete legal coverage via our international alliance network Consulting and Training Science Consulting -Training Services and Information Seminars Risk legal risk management plans -Helping to avoid, reduce & transfer legal risk -Ad hoc services for dealing with unexpected events Please see our homepage for more information.

11 to 50 staff

Jiantong Pharmaceuticals Ltd

Pharmaceutical company based in Taichung, Taiwan.

1 to 10 staff

Taron Solutions Limited

Taron Solutions Limited is a rising global contract translational, development, and manufacturing organization (CTDMO) with focus on cell/gene therapy and biologic drug products. Unlike traditional CDMOs, we love to provide solutions and we do not believe in a black box approach to projects. We work closely with clients to ensure that the project design makes sense within the time and budget and will meet all regulatory requirements to ensure right-the-first time. This means we will ensure frequent communication with our project management and scientific leads every step of the way. We specializes in the following: 1) Gene and cell line design and development 2) Upstream + downstream drug development 3) CMC study design and execution by QbD

11 to 50 staff

Cvc Technologies Group

CVC Technologies Inc.'s mission is to provide extraordinary value made possible by volume production and worldwide distribution, thus allowing modest pricing for machinery that meets and exceeds industry standards. OUR COMMITMENT TO OUR CUSTOMERS CVC Technologies Inc. is committed to one goal, helping our customers find the best possible solution to their packaging needs. Quality, Value, and Service are the parameters within which CVC defines its business philosophy. We commit to all CVC customers to supply excellent equipment and technical service to maximize their production efficiency, reduce operating costs and insure quality products. According to customer needs, we provide customized solutions for production packaging lines to meet the requirements of various automated packaging lines.

201 to 500 staff

Grand Pan-Well International Co., Ltd

Grand Pan-Well International Co, Ltd is a pharmaceutical importer/distributor in Taiwan dedicated to providing good quality pharmaceutical, medical device, and nutritional supplement products with affordable price to the public. We are keen to work with quality supplier from overseas, especially Europe and Northern America. We are currently looking for Bio-similar products, Generic Drugs, Medical Device, and innovative formulations for food supplements.

11 to 50 staff

Alar Pharmaceuticals Inc

Alar Pharmaceuticals Inc.(abbreviated as Alar), a new drug development company, was established in 2016. We focus on developing long-acting release drug products for CNS disorders and chronic diseases, which mainly include opioid use disorder, chronic pain, and major depressive disorder.

11 to 50 staff

Utek Inco

200120032011 #Pharmaceutical Industry

11 to 50 staff

Chirogate International Inc

Chirogate was founded in by a group of chemical scientists and technology professionals. With a strong technical background, we found it advantageous to work on niche-market molecules such as PGs because this group of products has long been considered difficult for artificial synthesis in terms of long reaction steps required and challenges in controlling the multi-chirality of the compound. The company was first started as a R&D laboratory. Very soon, we made remarkable progress in product development and successfully turned from a laboratory into a professional API supplier. Over the years, we have achieved remarkable growth on the market, amassing over 64 patents worldwide and have become a competitive manufacturer in prostaglandin field. By developing our own novel proprietary processes and cutting-edge technology platforms, we supply high quality prostaglandin products worldwide. More importantly, we have never forgotten the importance of GMP and have invested a lot in implementing quality system. Right from the receipt of raw materials to the dispatch of finished products, all activities are carried out in full compliance of cGMP regulations as well as international drug manufacturing codes. Serious attention to every manufacturing detail ensures the quality, safety and reliability of our products. Successful inspections by customers, authorities and especially US FDA make the best explanation itself. We work with customers in both regulated and non-regulated markets all over the world by supplying highest quality products with competitive prices. We value different requirements from customers and always pursue our best to our customers’ satisfaction. Chirogate's continuous dedication to developing proprietary technology and to improving product quality is an eternal promise to customers.

51 to 200 staff

Taiwan Bio Therapeutics Inc

Taiwan Biotech Therapeutics is a clinical-stage biotech company focusing on developing novel cell therapies. Our proprietary technology platforms enable us to perform safe and effective cell engineering, making our cell products more potent than conventional cell therapies.

51 to 200 staff

Usin Advance Co., Ltd

OMPI(EZ-fill™ Vials & Cartridges & Syringe) CMP(Inspection & Leak Test Machines) PIERCAN(Hypalon,Butyl, Neoprene Gloves) ACTINI(Effluent decontamination systems) MK(Glove testing systems) PEA(Pioneer of Hydrogen Peroxide(H2O2) Gassing) Bausch(Filling Closing Machine) FlowMarker(Visualisation and Measurement of AirFlow) Ezi-Dock(High Quality Liquid and Dust Free Powder Handling and Transfer solutions) Solo Containment(Powder Processing Isolators) YAMAMOTO(Safety Goggles)

11 to 50 staff

Holy Stone Healthcare Co., Ltd

Holy Stone Healthcare Co, Ltd, founded in January 2001, is a subsidiary of Holy Stone Enterprise. Holy Stone Healthcare is committed to developing potential medical and biotech products. We are an international biotech company with several subsidiaries around the world. Till now, several patented biotech products were successfully developed and launched into the international market through our European subsidiaries.

51 to 200 staff

Pharmasaga

Pharmasaga is an Academia Sinica-derived biotech company, and was founded in Jan-2021. The core technology of Pharmasaga is the inhibitor of PX protein, which plays a critical role in diabetes development. Dr. Yang in Academia Sinica had researched the mechanism of diabetes for more than 20 years, and the technology of diabetes treatment was transferred to Pharmasaga for commercialization.

1 to 10 staff

Clinny Biotech Limited

Clinny Biotech Limited is a Taiwan local CRO. Our company specializes in clinical study management, product registration and medical sciences. The experienced therapeutic area includes Oncology, Neurology, Pediatric, Internal Medicine, and Obstetrics & Gynecology. The team at our firm are the best in their own way and we promise to provide timely and qualified services to our clients.

1 to 10 staff

Mingtai Chemical Co., Ltd

We are known globally as a manufacturer and supplier of high-quality products in the pharmaceutical, food and the cosmetics and personal care industries in Taiwan. With more than 50 years of experience in manufacturing excipients, we have established a reliable brand reputation. It is our unwavering commitment to make headway to drive a total customer satisfaction. To build customer trust, we opted to perpetually pursue improvement of our product quality, production efficiency, sales services, and management methods. We are poised to continue scale up our business and strengthen our market position by honing production expertise and expanding our manufacturing facilities for the reaping market demand. The growth of Mingtai is noticeable with accumulated experience and non-stop improvement in quality. Our business has significantly increased over the years and has taken root in over 80 countries with our local partners. We have now more than regular customers which have empowered us to gain acceptance and recognition worldwide as a leading excipient manufacturer. Our Products: Comprecel® - Microcrystalline Cellulose (MCC) Disolcel®- Croscarmellose Sodium (CCS) Neocel® - Microcrystalline Cellulose and Carboxymethylcellulose Sodium (Colloidal MCC) Comprecel®SMCC - Silicified Microcrystalline Cellulose (SMCC) Our products can be used as a binder, filler, anti-caking agent, disintegrant, suspending agent, thickener, emulsion stabilizer and more. Learn more about us at our official website:

51 to 200 staff

Wei Ming Pharmaceutical

We market and supply international problem-solving specialty ingredients for the pharma, nutrition, and cosmetic sectors with over 50 years of industry experience. Our other areas of business include-Producer of pharma excipient Microcrystalline Cellulose (MCC)-Better-Iodine Ointment/Solutions OTC (Povidone-Iodine )-A large portfolio of cosmetic and nutraceutical products: BIOPEUTIC cosmeceuticals, AstaPeutic nutraceuticals, and PURETRIENT a physician-only product line.

51 to 200 staff

Aseptic Innovative Medicine Aim

Aseptic Innovative Medicine Co, Ltd. has been developing and producing medicines to improve people’s lives for more than two decades. We are main supplier in generic eye drops in medical institution of Taiwan, based on abundant resource from our parent company, Taiwan Biotech Co, Ltd. We are committed to providing access to affordable and innovative medicines, driven by our purpose of ‘For a Better Life’.

51 to 200 staff

Oep Pharma

OEP Pharma is a full-service, global pharmaceutical company. Leveraging its R&D capabilities and commercial infrastructure in Asia, OEP Pharma develops, manufactures, and commercializes branded and generic medicines. OEP Pharma is the U.S. headquarters of OEP Group, a TWSE-listed pharmaceutical company founded in Taiwan in 1982. With a market cap of $200 million USD and employees worldwide, OEP has a 40-year track record as a distributor of choice in Taiwan and ASEAN countries. Today, OEP has a growing generics and specialty pharma product portfolio and pipeline, experienced salesforce in 10 countries, and distribution partners in North America. Its FDA-approved oral dosage facility, and injectables facility (FDA approval expected early 2021) specialize in complex formulations, including highly potent compounds, modified release products, and poorly soluble compounds.

501 to 1000 staff

Technoco

Technoco Co, Ltd was established in 1993 at Taipei, Taiwan with strong and firm supporting from manufacturers in the fields of active pharmaceutical ingredients and fine chemicals. Our activities are not limited to the introduction of active pharmaceutical ingredients but also pharmaceutical excipients; intermediates for active pharmaceutical ingredients and fine chemicals, ex. UV absorbers for sunscreen products; anti-oxidants and light stabilizers for plastic industry as additives, and ingredients for nutrition and cosmetic. In addition to supplying products based on customer’s demand, we are proudly to highlight our expertise on developing new active pharmaceutical ingredients and its intermediates with own R&D team according to customer’s requirements and to organize toll manufacturing on behalf of the customers. Our commitment is to only recommend and work with manufacturers in compliance of cGMP standard since our core value is to treasure what we have been entrusted and to honor what we committed to.

11 to 50 staff

Mycenax Biotech Inc

Established in 2001, Mycenax is a dedicated CDMO specializing in process development and GMP production for innovative biologics. With our extensive expertise in developing biologic products, we offer a comprehensive range of solutions, including mAb, bi-specific (BsAb), multi-specific antibodies, ADCs/PDCs, plasmid DNA, fusion proteins, vaccines and cell therapy products. Leveraging our advanced platforms and PIC/S GMP-compliant manufacturing facilities, we provide time- and cost-effective one-stop services to clients worldwide.

201 to 500 staff

Nang Kuang Pharmaceutical Co. Ltd

Nang Kuang, founded in 1963, is a leading pharmaceutical company in Taiwan, with almost 55 year history,esp. in production of injectable, with key products including large volume parenterals ( LVP; PP-soft bag), aseptic parenterals (AmpouleVial) lyophilized injectionPre-filled syringePre-mixed IV infusion bags and also tablets(including film coating ) capsulestopical productsoral suspensions. Accredited with superior product quality, innovative technology, and outstanding production capacity, Nang Kuang has become the largest injectable manufacturer in the country. With annual sales approximately 1,800 million NT dollars (approx. US $50 million) and an existing workforce of close to 570 employees, Nang Kuang company had gone public in Taiwan 2009. Nang Kuang has been certified by the Taiwan Bureau of Health with respect to cGMPPIC/S GMP(whole factory) compliance and was also granted ISO14001TIPS(Taiwan Intellectual Property Scheme) certification along with many export product licenses(we are first to export injectable medicine to Japan market successfully, in 17 years ago). The high quality of our exported products has earned Nang Kuang an excellent reputation from our clients all over the world. Our company has developed a global business strategy for exploring market opportunities in Japan, China, and southeast Asian countries. Co-marketing arrangements with many pharmaceutical companies in Europe and United States have also been established. Providing the public with the best quality medicines in the quest for good health for all."Providing the public with the best quality medicines in the quest for good health for all" is our corporate mission. This mission is supported by our best corporate practices in recruiting talents, advancing R&D capabilities, strengthening our core business, and sustaining our competitive advantages.

501 to 1000 staff

Amaran Biotech

As a leading Contract Development and Manufacturing Organization (CDMO), Amaran Biotech specializes in delivering high-value biopharmaceutical services. Our elite team demonstrates exceptional execution capabilities in process development, optimization, and clinical production. Leveraging cutting-edge technology and solid expertise, we continuously innovate to meet evolving industry demands. Amaran Biotech supports our clients, accelerates drug development, and advances human health.

51 to 200 staff

Medical And Pharmaceutical Industry And Technology Development Center Pitdc

PITDC is a non-profit organization established by the Industrial Development Bureau, the Ministry of Economic Affairs, Taiwan. The main aim is to the support the development and internationalization of the domestic pharmaceutical and technology industries. Our center has a lab for R&D in both formulation and manufacturing process development. In recent years our department started to focus on the internationalization of Taiwanese pharmaceutical products and eventually established the Taiwan Pharmaceutical Alliance (TPA). The TPA members comprise the largest Taiwanese pharmaceutical manufacturers of Active Pharmaceutical Ingredient (API) and Finished Dosage Forms (FDF), and most of them have successfully set up the product markets in ASEAN, South America, Japan, US or EU regions. Taiwan is one of the country members of PIC/S and ICH and all of our facilities are PIC/S GMP certified. Some of them have passed the inspection and obtained certification from the USFDA, Japan or EU authorities. In summary, PITDC acts as a matchmaker that helps fulfilling the global pharmaceutical market demands with the abundant resources and new technologies from the Taiwanese manufacturers. We have invested and carried out a tonnes of global pharmaceutical market studies, which resulted in a wide array of potential drug candidates in our strategies that can enter and perform very well in global drug markets.

201 to 500 staff

Tfbs Bioscience, Inc

TFBS Bioscience Inc. is a certified and leading GMP Viral Vector Contract Development and Manufacturing Organization in Asia-Pacific and the first specialist viral vector provider in Taiwan. With the expertise in manufacturing and comprehensive testing services, we always stand by our clients and help them clarify their needs and what should be done through continuous communication. We are proud of our total solution service and flexible scheduling that consistently supports our clients to get their products into the market as quickly as possible.

51 to 200 staff

Glyconex Inc

GlycoNex Inc. was founded in 2001, in alliance with The Biomembrane Institute (TBI) from Washington University and Dr. Sen-Itiroh Hakomori, a member of the National Academy of Sciences (USA). GlycoNex was the first pharmaceutical company in Taiwan to combine cancer-related glycan identification with human monoclonal antibody development. GlycoNex Inc. possesses a complete and detailed technological platform for anti-glycan antibody development, including multiple acquired licensed patents. Our pipeline consists of new drug development in parallel with biosimilars. Our new drugs were selected and developed through a detailed antigen/antibody characterization and cell line development. In 2009, we licensed GNX8 to Otsuka Pharmaceutical Co, Ltd. In 2019, our first-in-class new drug GNX102 received FDA IND approval. In 2020, we initiated our Clinical Trial Phase I dose-escalation study for GNX102 and received TFDA IND approval. In parallel, our biosimilar products Denosumab and Aflibercept have completed different volumes of pilot studies, and data are ready for review. We aim to look for opportunities to out-license our products or co-develop in cooperation.

51 to 200 staff

Lotus Pharmaceutical Co., Ltd

1795 1966 100 250 505b2 NCE FDA EMA PDMA FDA ANVISA Founded in 1966, Lotus (1795: TT) is an international pharmaceutical company with global presence, focused on commercializing novel and generic pharmaceuticals, offering patients better, safe and more accessible medicines. The Company has a recognized best-in-class R&D and manufacturing platform in Asia and has established partnerships in nearly every global market including the U.S, Europe, Japan, China, and Brazil. Lotus runs over 100 strategically selected pharmaceutical projects in development and registrations across Asia and the US, with over 250 commercial products. The Company invests in diversified best portfolio consisting of high-barrier oncology, complex generics as well as 505(b)2 and NCE via internal R&D investment and licensing-in partnership, and also strengthens its portfolio competitiveness by adding biosimilar products with support from strategic partners. Its industry-leading infrastructure certified by most of the advanced regulatory authorities around the world, including US FDA, EU EMA, Japan PMDA, China FDA, and Brazil ANVISA.

1001 to 5000 staff

Pharmadax Inc

PHARMADAX focuses on developing and manufacturing specialty generic medicines. We commenced our business in 2008 and headquartered in Taipei, Taiwan. Our Vision is to build a leading generic specialty pharmaceutical company with enhanced focus on specialty modified release products and become preferred development partner for global organizations. We are present in US, EU, China and Taiwan and expanding presence in other emerging markets through dossier registrations. Our manufacturing site is located in China with facility accredited by USFDA.

201 to 500 staff

Amed Co., Ltd

Medical and Medical Device

51 to 200 staff